Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST

References

• Aranda A, Sequedo L, Tolosa L, Quintas G, Burello E, Castell JV, Gombau L. 2013. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol in Vitro 27:954–63
   PubMed Web of Science ®Google Scholar
• Bouwmeester H, Lynch I, Marvin HJP, Dawson KA, Berges M, Braguer D, et al. 2011. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5:1–11
   PubMed Web of Science ®Google Scholar
• Burello E, Worth A. 2011. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 5:228–35
   PubMed Web of Science ®Google Scholar
• Burello E, Worth A. 2015. A rule for designing safer nanomaterials: do not interfere with the cellular redox equilibrium. Nanotoxicology 9(S1):116–117
   Google Scholar
• Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, Rytting E. 2011. In vitro placental model optimization for nanoparticle transport studies. Int J Nanomed 7:497–510
   Google Scholar
• Correia Carreira S, Walker L, Paul K, Saunders M. 2015. The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST. Nanotoxicology 9(S1):66–78
   Google Scholar
• Cowie H, Magdolenova Z, Saunders M, Drlickova M, Correia Carreira S, Halamoda Kenzaoiu B, et al. 2015. Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles. Nanotoxicology 9(S1):57–65
   Google Scholar
• dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. 2011. Quantitative assessment of the comparative nanoparticle-uptake efficiency of arrange of cell lines. Small 7:3341–9
   PubMed Web of Science ®Google Scholar
• Dusinska M, Fjellsbø LM, Magdolenova Z, Ravnum S, Rinna A, Runden-Pran E. 2011. Chapter 11. Safety of nanomaterial in nanomedicine. In: Hunter RJ, Preedy VR, eds. Nanomedicine in Health and Disease. New Hampshire: Science Publishers [CRC Press], 203–26
   Google Scholar
• Dusinska M, Magdolenova Z, Fjellsbø LM. 2013. Toxicological aspects for nanomaterial in humans. Chapter 1. In: Oupicky D, Ogris M, eds. Nanotechnology for Nucleic Acid Delivery, Methods in Molecular Biology. New York: Humana Press, Springer BWF Book 948, 1–12
   Google Scholar
• Dusinska M, NanoTEST consortium. 2009. Safety of nanoparticles used in medical application. Development of alternative testing strategies for toxicity testing. Sci Technol Public Serv Rev 4:126–7
   Google Scholar
• Dusinska M, Rundén-Pran E, Carreira SC, Saunders M. 2012. In vitro and in vivo toxicity test methods. Chapter 4. Critical Evaluation of Toxicity Tests. In: Fadeel B, Pietroiusti A, Shvedova A, eds. Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology and Impact on Human Health. New York: Elsevier, 63–84
   Google Scholar
• Elsaesser A, Barnes CA, McKerr G, Salvati A, Lynch I, Dawson KA, Howard CV. 2011. Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) 6(7):1189–98
   PubMed Web of Science ®Google Scholar
• Elsaesser A, Howard CV. 2012. Toxicology of nanoparticles. Adv Drug Deliv Rev 64:129–37
   PubMed Web of Science ®Google Scholar
• Gonzalez L, Corradi S, Thomassen LC, Martens JA, Cundari E, Lison D, Kirsch-Volders M. 2011. Methodological approaches influencing cellular uptake and cyto-(geno) toxic effects of nanoparticles. J Biomed Nanotechnol 7:3–5
   PubMed Web of Science ®Google Scholar
• Guadagnini R, Halamoda Kenzaoui B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015a. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):13–24
   Google Scholar
• Guadagnini R, Moreau K, Hussain S, Marano F, Boland S. 2015b. Toxicity evaluation of engineered nanoparticles for medical applications for the pulmonary system. Nanotoxicology 9(S1):25–32
   Google Scholar
• Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ. 2007. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 49:217–29
   PubMed Web of Science ®Google Scholar
• Halamoda Kenzaoui B, Angeloni S, Overstolz T, Niedermann P, ChapuisBernasconi C, Liley M, Juillerat-Jeanneret L. 2013a. Transfer of ultra small iron oxide nanoparticles from human brain-derived endothelial cells to human glioblastoma cells. ACS Appl Mater Interfaces 5:3581–6
   PubMed Web of Science ®Google Scholar
• Halamoda Kenzaoui B, Bernasconi C, Hofmann H, Juillerat-Jeanneret L. 2012a. Evaluation of uptake and transport of ultra small super paramagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine 7:39–53
   PubMed Web of Science ®Google Scholar
• Halamoda Kenzaoui B, Chapuis Bernasconi C, Guney-Ayra S, Juillerat-Jeanneret L. 2012c. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain endothelial cells. Biochem J 441:813–21
   PubMed Web of Science ®Google Scholar
• Halamoda Kenzaoui B, Chapuis Bernasconi C, Juillerat-Jeanneret L. 2013b. Stress-reaction of kidney epithelial cells to inorganic solid-core nanoparticles. Cell Biol Toxicol 29:39–58
   PubMed Web of Science ®Google Scholar
• Halamoda Kenzaoui B, Vila MR, Miquel JM, Cengelli F, Juillerat-Jeanneret L. 2012b. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomed, 7:1275–86
   PubMed Web of Science ®Google Scholar
• Handy RD, van den Brink N, Chappell M, Mühling M, Behra R, Dusinska M, et al. 2012. Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far? Ecotoxicology 21:933–72
   PubMed Web of Science ®Google Scholar
• Harris G, Palosaari T, Magdolenova Z, Mennecozzi M, Gineste JM, Saavedra L, et al. 2015. Iron oxide nanoparticle toxicity testing using high throughput analysis and high content imaging. Nanotoxicology 9(S1):87–94
   Google Scholar
• Hassellöv M, Kaegi R. 2009. Analysis and characterization of manufactured nanoparticles in aquatic environments. In: Lead JR, Smith E, eds. Environmental and Human Health Impacts of Nanotechnology. West Sussex, United Kingdom: Blackwell Publishing Ltd, 211–66
   Google Scholar
• Hussain S, Thomassen LCJ, Ferecatu I, Borot C, Andreau K, Martens JA, et al. 2010. Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol 7:10
   PubMed Web of Science ®Google Scholar
• Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–89
   Web of Science ®Google Scholar
• Juillerat-Jeanneret L, Dusinska M, Fjellesbo LM, Collins AR, Handy R, Riediker M. 2015. Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project. Nanotoxicology 9(S1):5–12
   Google Scholar
• Juillerat-Jeanneret L, Aguzzi A, Wiestler OD, Darekar P, Janzer RC. 1992. Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines. In Vitro Cell Dev Biol 28A:537–43
   Google Scholar
• Karlsson HL. 2010. The comet assay in nanotoxicology research. Anal Bioanal Chem 398:651–66
   PubMed Web of Science ®Google Scholar
• Kato H, Suzuki M, Fujita K, Horie M, Endoh S, Yoshida Y, et al. 2009. Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. Toxicol in Vitro 23:927–34
   PubMed Web of Science ®Google Scholar
• Kazimirova A, Magdolenova Z, Barancokova M, Staruchova M, Volkovova K, Dusinska M. 2012. Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. Mutat Res 748:42–7
   PubMed Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2012. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 86:1123–36
   PubMed Web of Science ®Google Scholar
• Laborda F, Jimenez-lamana J, Bolea E, Castillo JR. 2013. Critical considerations for the determination of nanoparticle number concentrations, size and number size distributions by single particle ICP-MS. J Anal Atomic Spectrom 28:1220–32
   Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, et al. 2011. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5:7503–9
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Bilaničová D, Pojana G, Fjellsbø LM, Hudecova A, Hasplova K, et al. 2012a. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 14:455–64
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Lorenzo Y, Collins A, Dusinska M. 2012b. Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health A 75:800–6
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Collins AR, Kumar A, Dhawan A, Stone V, Dusinska M. 2014. Mechanisms of genotoxicity. Review of recent in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology 8:233–78
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Drlickova M, Henjum K, Rundén-Pran E, Tulinska J, Bilanicova D, et al. 2015. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology 9(S1):44–56
   Google Scholar
• Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA. 2012. Designing the nanoparticle-biomolecule interface for “targeting and therapeutic delivery". J Control Release 161:164–74
   PubMed Web of Science ®Google Scholar
• Mortensen NP, Hurst GB, Wang W, Foster CM, Nallathamby PD, Retterer ST. 2013. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 5:6372–80
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part FibreToxicol 2:8
   PubMed Web of Science ®Google Scholar
• OECD. 2012. Environment, health and safety publications series on the safety of manufactured nanomaterials No. 36. Guidance on sample preparation and dosimetry for the safety testing of manufactured nanomaterials. ENV/JM/MONO(2012) 40:1–93
   Google Scholar
• Pilou M, Mavrofrydi O, Housiadas C, Eleftheriadis K, Papazafiri P. 2015. Computational modeling as part of an alternative testing strategies in the respiratory and cardiovascular systems: inhaled nanoparticle dose modeling based on representative aerosol measurements and corresponding toxicological analysis. Nanotoxicology 9(S1):106–115
   Google Scholar
• Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting E. 2015. Kinetics of silica nanoparticles in the human placenta. Nanotoxicology 9(S1):79–86
   Google Scholar
• Powers KW, Palazuelos M, Moudgil BM, Roberts SM. 2007. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1:42–51
   Web of Science ®Google Scholar
• Ragnaill MN, Brown M, Ye D, Bramini M, Callanan S, Lynch I, Dawson KA. 2011. Internal bench-marking of a human blood–brain barrier cell modelling for screening of nanoparticle uptake and transcytosis. Eur J Pharm Biopharm 77:360–7
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia S, Chen L, Morris MA, Dawson KA. 2011. A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. Nanoscale 3:4617–24
   PubMed Web of Science ®Google Scholar
• Saunders M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671–84
   PubMed Web of Science ®Google Scholar
• Schütz CA, Staedler D, Crosbie-Staunton K, Movia D, Chapuis Bernasconi C, Halamoda Kenzaoui B, et al. 2014. Differential stress reaction of human colon cells to oleic acid-stabilized and unstabilized ultra small iron oxide nanoparticles. Int J Nanomed 9:3481–98
   PubMed Web of Science ®Google Scholar
• Sebekova K, Dusinska M, Simon Klenovics K, Kollarova R, Boor P, et al. 2014. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra small super paramagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats. Nanotoxicology 8:142–57
   PubMed Web of Science ®Google Scholar
• Stefaniak AB, Hackley VA, Roebben G, Ehara K, Hankin S, Postek MT, et al. 2013. Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 7:1325–37
   PubMed Web of Science ®Google Scholar
• Stone V, Johnston H, Schins RPF. 2009. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613–26
   PubMed Web of Science ®Google Scholar
• Stone V, Nowack B, Baun A, van den Brink N, von der Kammer F, Dusinska M, et al. 2010. Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterization. Sci Total Environ 408:1745–54
   PubMed Web of Science ®Google Scholar
• Taurozzi JS, Hackley AH, Wiesner MR. 2011. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment – issues and recommendations. Nanotoxicology 5:711–29
   PubMed Web of Science ®Google Scholar
• Tulinska J, Kazimirova A, Kuricova M, Barancokova M, Liskova A, Neubauerova E, et al. 2015. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model. Nanotoxicology 9(S1):33–43
   Google Scholar
• Volkovova K, Handy R, Ulicna O, Kucharska J, Staruchova M, Kebis A, et al. 2015. Health effects of selected nanoparticles in vivo: Liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate coated iron oxide nanoparticles in rodents. Nanotoxicology 9(S1):95–105
   Google Scholar
• Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183–5
   PubMed Web of Science ®Google Scholar
• Wittmaack K. 2011. Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. ACS Nano 5:3766–78
   PubMed Web of Science ®Google Scholar
• Yang ST, Liu Y, Wang YW, Cao A. 2013. Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. Small 9:1635–53
   PubMed Web of Science ®Google Scholar
• Zuin S, Pojana, G, Marcomini, A. 2007. Effect-oriented physicochemical characterization of nanomaterials. In: Monteiro-Riviere NA, Tran CL, eds. Nanotoxicology: Characterization, Dosing and Health Effects. 1st ed. New York: Informa Healthcare, 19–57
   Google Scholar